A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure

A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure

Background: High-flow nasal cannula (HFNC) has been recommended as a suitable choice for the management of coronavirus disease 2019 (COVID-19) patients with acute hypoxemic respiratory failure before mechanical ventilation (MV); however, delaying MV with HFNC therapy is still a dilemma between the t...

Full description

Bibliographic Details
Main Authors: Jiqian Xu, Xiaobo Yang, Chaolin Huang, Xiaojing Zou, Ting Zhou, Shangwen Pan, Luyu Yang, Yongran Wu, Yaqi Ouyang, Yaxin Wang, Dan Xu, Xin Zhao, Huaqing Shu, Yongxiang Jiang, Wei Xiong, Lehao Ren, Hong Liu, Yin Yuan, Hong Qi, Shouzhi Fu, Dechang Chen, Dingyu Zhang, Shiying Yuan, You Shang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Medicine
Subjects:
COVID-19
HFNC
ROX
mechanical ventilation
thrombocytopenia
risk-stratification
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2020.607821/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2020.607821/full

Similar Items